Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer

NCT06930755 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: NMS-03305293
DRUG: Topotecan

Sponsor

Nerviano Medical Sciences